Across Europe chronic diseases (such as cardiovascular and respiratory disease, type 2 diabetes and chronic kidney disease) account for 86% of all deaths each year, though rates vary between and within countries due to stark inequalities in health. Chronic diseases have a large impact on health care costs throughout the European Union (EU).
Globally, the magnitude of the chronic disease burden has been recognised. The EConDA (Economics of Chronic Diseases) project is considering recommendations for integrated interventions, performing an economic evaluation of the investment required, expected outcome and possibility for scaling up/transferring experiences across Europe.
The key aim is to aid EU Member States to develop, select and implement more cost-effective policies to improve chronic disease prevention and impact upon populations with the highest rates of premature deaths from chronic diseases and reduce health inequalities.
The specific objectives are to:
- seek consensus among relevant experts, policy makers and international organisations on the methodology for measuring cost-effectiveness of interventions to prevent, screen and treat chronic diseases taking into consideration the cost of externalities.
- develop a demonstration model for integrated approaches to address cost-effectiveness of various interventions for chronic disease prevention, particularly to demonstrate the differential effects of interventions on various population sub groups.
EConDA is funded by the European Commission Consumers, Health and Food Executive Agency. Health Equalities Group work with a number of partners on the EConDA project and provide the evaluation element.